{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:41:41Z","timestamp":1791819701441,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.hpb.2025.10.014","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T16:02:40Z","timestamp":1762012960000},"page":"78-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The \u201cBig short\u201d of minimally invasive pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. A cost-effectiveness analysis based on randomized trials"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6638-4479","authenticated-orcid":false,"given":"Claudio","family":"Ricci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Alberici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"D'Ambra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Ingaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Fichera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Casadei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2025.10.014_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/SLA.0000000000003590","article-title":"The Miami international evidence-based guidelines on minimally invasive pancreas resection","volume":"271","author":"Asbun","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2025.10.014_bib2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1590\/s0102-865020180010000005","article-title":"Laparoscopic versus open pylorus-preserving pancreatoduodenectomy. The first meta-analyses of retrospective matched cases","volume":"33","author":"Pang","year":"2018","journal-title":"Acta Cir Bras"},{"key":"10.1016\/j.hpb.2025.10.014_bib3","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/bjs.10662","article-title":"Randomized clinical trial of laparoscopic versus open pancreatoduodenectomy for periampullary tumours","volume":"104","author":"Palanivelu","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.hpb.2025.10.014_bib4","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/SLA.0000000000002893","article-title":"Comparison of perioperative outcomes between laparoscopic and open approach for pancreatoduodenectomy: the PADULAP randomized controlled trial","volume":"268","author":"Poves","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2025.10.014_bib5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S2468-1253(19)30004-4","article-title":"Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2\/3 trial","volume":"4","author":"van Hilst","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.hpb.2025.10.014_bib6","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S2468-1253(21)00054-6","article-title":"Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours: a multicentre, open-label, randomised controlled trial","volume":"6","author":"Wang","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.hpb.2025.10.014_bib7","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.hpb.2019.05.017","article-title":"A meta-analysis of randomized controlled trials comparing laparoscopic vs open pancreaticoduodenectomy","volume":"21","author":"Ausania","year":"2019","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.hpb.2025.10.014_bib8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/SLA.0000000000003309","article-title":"Laparoscopic versus open pancreaticoduodenectomy: a systematic review and meta-analysis of randomized controlled trials","volume":"271","author":"Nickel","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2025.10.014_bib9","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1007\/s00464-022-09660-6","article-title":"Trial sequential meta-analysis of laparoscopic versus open pancreaticoduodenectomy: is it the time to stop the randomization?","volume":"37","author":"Ricci","year":"2023","journal-title":"Surg Endosc"},{"key":"10.1016\/j.hpb.2025.10.014_bib10","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S2468-1253(21)00059-5","article-title":"Laparoscopic pancreatoduodenectomy: extensive learning curve, marginal benefits","volume":"6","author":"Schneider","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.hpb.2025.10.014_bib11","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s00268-017-4180-7","article-title":"Minimally invasive pancreaticoduodenectomy: what is the best \u201cChoice\u201d? A systematic review and network meta-analysis of non-randomized comparative studies","volume":"42","author":"Ricci","year":"2018","journal-title":"World J Surg"},{"key":"10.1016\/j.hpb.2025.10.014_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.21037\/hbsn-23-132","article-title":"International consensus guidelines on robotic pancreatic surgery in 2023","volume":"1","author":"Liu","year":"2024","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.hpb.2025.10.014_bib13","article-title":"Robotic versus open partial pancreatoduodenectomy (EUROPA): a randomised controlled stage 2b trial","volume":"22","author":"Klotz","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.hpb.2025.10.014_bib14","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S2468-1253(24)00005-0","article-title":"Effect of robotic versus open pancreaticoduodenectomy on postoperative length of hospital stay and complications for pancreatic head or periampullary tumours: a multicentre, open label randomised controlled trial","volume":"9","author":"Liu","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.hpb.2025.10.014_bib15","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1007\/s11605-017-3466-2","article-title":"Analysis of the cost effectiveness of laparoscopic pancreatoduodenectomy","volume":"21","author":"Gerber","year":"2017","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.hpb.2025.10.014_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jval.2021.11.1351","article-title":"CHEERS 2022 ISPOR Good Research Practices Task Force. Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations","volume":"25","author":"Husereau","year":"2022","journal-title":"Value Health"},{"key":"10.1016\/j.hpb.2025.10.014_bib17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jclinepi.2020.01.008","article-title":"A full systematic review was completed in 2 weeks using automation tools: a case study","volume":"121","author":"Clark","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.hpb.2025.10.014_bib18","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0002-9343(82)90786-0","article-title":"A convenient approximation of life expectancy (the \"DEALE\"). I. Validation of the method","volume":"73","author":"Beck","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.hpb.2025.10.014_bib19","series-title":"Manual for cost research. Dutch manual. Update appeared in 2004 and 2010","author":"Hakkaart-van Roijen","year":"2010"},{"key":"10.1016\/j.hpb.2025.10.014_bib20","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2471\/BLT.15.164418","article-title":"Cost-effectiveness thresholds: pros and cons","volume":"94","author":"Bertram","year":"2016","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.hpb.2025.10.014_bib22","series-title":"Making choices in health: WHO guide to cost-effectiveness analysis","year":"2003"},{"key":"10.1016\/j.hpb.2025.10.014_bib25","series-title":"Manual for cost research. Dutch manual. Update appeared in 2004 and 2010","author":"Hakkaart-van Roijen","year":"2010"},{"key":"10.1016\/j.hpb.2025.10.014_bib26","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.hpb.2020.09.002","article-title":"The use of comprehensive complication index\u00ae in pancreatic surgery: a comparison with the Clavien-Dindo system in a high-volume center","volume":"23","author":"Ricci","year":"2021","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.hpb.2025.10.014_bib27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12957-024-03393-7","article-title":"Adjuvant chemotherapy omission after pancreatic cancer resection: a French nationwide study","volume":"22","author":"Poiraud","year":"2024","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.hpb.2025.10.014_bib28","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1245\/s10434-024-14951-4","article-title":"Adjuvant therapy after upfront resection of resectable pancreatic cancer: patterns of omission and Use-A prospective real-life study","volume":"31","author":"Paiella","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2025.10.014_bib29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/SLA.0000000000003223","article-title":"Benchmarks in pancreatic surgery: a novel tool for unbiased outcome comparisons","volume":"270","author":"S\u00e1nchez-Vel\u00e1zquez","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2025.10.014_bib30","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jamaoncol.2022.3829","article-title":"Canadian Cancer Trials Group and the Unicancer-GI\u2013PRODIGE Group, Five-year outcomes of FOLFIRINOX vs gemcitabine as adjuvant therapy for pancreatic cancer: a randomized clinical trial","volume":"8","author":"Conroy","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.hpb.2025.10.014_bib31","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/jama.2013.279201","article-title":"Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial","volume":"310","author":"Oettle","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.hpb.2025.10.014_bib33","doi-asserted-by":"crossref","first-page":"451","DOI":"10.6004\/jnccn.2020.7798","article-title":"Potential cost-effectiveness of risk-based pancreatic cancer screening in patients with new-onset diabetes","volume":"20","author":"Schwartz","year":"2021","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.hpb.2025.10.014_bib34","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s00464-022-09440-2","article-title":"The impact of disclosure of conflicts of interest in studies comparing robot-assisted and laparoscopic cholecystectomies-a persistent problem","volume":"37","author":"Myneni","year":"2023","journal-title":"Surg Endosc"},{"key":"10.1016\/j.hpb.2025.10.014_bib35","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/SLA.0000000000002420","article-title":"Assessment of conflicts of interest in robotic surgical studies: validating author's declarations with the open payments database","volume":"268","author":"Patel","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2025.10.014_bib36","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/SLA.0000000000003000","article-title":"The impact of corporate payments on robotic surgery research: a systematic review","volume":"269","author":"Criss","year":"2019","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.hpb.2025.10.014_bib37","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/SLA.0000000000006454","article-title":"International study group for pancreatic surgery. Complexity and experience grading to guide patient selection for minimally invasive pancreatoduodenectomy: an ISGPS consensus","volume":"281","author":"Barreto","year":"2025","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2025.10.014_bib38","first-page":"673","article-title":"Methods for the economic evaluation of health care interventions for priority setting in the health system: an update from WHO CHOICE","volume":"10","author":"Bertram","year":"2021","journal-title":"Int J Health Pol Manag"},{"key":"10.1016\/j.hpb.2025.10.014_bib39","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/MPA.0b013e318216f693","article-title":"Clinical and patient-reported outcomes after pancreatoduodenectomy for different diseases: a follow-up study","volume":"40","author":"Pezzilli","year":"2011","journal-title":"Pancreas"},{"key":"10.1016\/j.hpb.2025.10.014_bib40","article-title":"Disentangling seemingly contradictory results of the first two randomised controlled trials comparing open and robotic pancreatoduodenectomy","volume":"40","author":"Boggi","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.hpb.2025.10.014_bib41","first-page":"1367","article-title":"Cost-effectiveness analysis of FOLFIRINOX vs gemcitabine with nab-paclitaxel as adjuvant treatment for resected pancreatic cancer in the United States based on PRODIGE-24 and APACT trials","volume":"27","author":"Kharat","year":"2021","journal-title":"J Manag Care Spec Pharm"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X25016776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X25016776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T05:43:57Z","timestamp":1775195037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X25016776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1365182X25016776"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2025.10.014","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The \u201cBig short\u201d of minimally invasive pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. A cost-effectiveness analysis based on randomized trials","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2025.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of International Hepato-Pancreato-Biliary Association Inc.","name":"copyright","label":"Copyright"}]}}